Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT07660003

8-OHdG and Oxidative Stress in Febrile Seizures

Conditions: Febrile Seizures Simple Febrile Seizure Complex Febrile Seizure; Oxidative Stress; Oxidative DNA Damage

Sex: All
Ages: 6 Months – 72 Months
Healthy volunteers: No
Enrollment: 156
Sponsor: Kayseri City Hospital

Location: Kayseri City Hospital Kayseri

Summary

This prospective case-control study investigates whether serum 8-hydroxy-2'-deoxyguanosine (8-OHdG), an established biomarker of reactive oxygen species-mediated DNA oxidation, is elevated in children with febrile seizures compared with healthy children, and whether it differs between simple and complex febrile seizure subtypes. Children presenting with a febrile seizure and age-matched healthy controls have serum 8-OHdG measured within 24 hours of seizure onset, alongside routine inflammatory markers (white-cell count, C-reactive protein) and haemoglobin. The primary aim is to determine whether acute oxidative DNA damage is detectable after febrile seizures and whether 8-OHdG levels distinguish simple from complex subtypes. The study is exploratory and hypothesis-generating; it is not designed to establish 8-OHdG as a clinically applicable diagnostic biomarker.

Eligibility Criteria

Inclusion Criteria: 1. Age between 6 and 72 months 2. Presentation with a febrile seizure (simple or complex) to the paediatric emergency department, OR healthy age- and sex-matched child (control group) 3) For seizure groups: a seizure occurring in the context of fever, meeting clinical criteria for simple or complex febrile seizure 4\) Serum sample obtainable within 24 hours of seizure onset (seizure groups) Written informed consent provided by a parent or legal guardian Exclusion Criteria: 1. Central nervous system (CNS) infection (e.g., meningitis, encephalitis) 2. Known epilepsy or prior afebrile seizures 3. Neurodevelopmental delay 4. Chronic systemic illness 5. Use of antioxidant supplements within the preceding 3 months 6. Incomplete clinical or laboratory data

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07660003). StuddyBuddy aggregates publicly available trial information.